Intrastromal versus subconjunctival anti-VEGF agents for treatment of corneal neovascularization: a rabbit study.
Rukiye Kilic UcgulSerdal CelebiNiyazi Samet YilmazNeslihan BukanAhmet Yucel UcgulPublished in: Eye (London, England) (2021)
Intrastromal anti-VEGF therapy regressed CoNV more effectively than subconjunctival therapy regardless of the type of anti-VEGF agent.